2025³â 08¿ù 07ÀÏ ¸ñ¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92567°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



ÅÂÇ×È£, MBC ¡®¸Þ¸® ųÁî ÇÇÇᯠÃ⿬

ºÎÇü»ç·Î º¯½Å, Á¶·Â»ç¸Á »ç°Ç ÃßÀû
¹è¿ì ÅÂÇ×È£°¡ Áö³­ 1ÀÏ Ã¹ ¹æ¼ÛµÈ MBC ±ÝÅäµå¶ó¸¶ ‘¸Þ¸® ųÁî ÇÇÇÃ’(±âȹ ±Ç¼ºÃ¢ / ¿¬Ãâ ¹ÚÁØ¿ì / ±Øº» À̼ö¾Æ / Á¦ÀÛ ¹Ì½ºÅͷθǽº, ¹«ºùÇÈÃĽºÄÄÆÛ´Ï, ½ºÆ©µð¿À ¾ÈÀÚÀÏ·»)À» ÅëÇØ ½ÃûÀÚµé°ú ¸¸³µ´Ù.   ‘¸Þ¸® ųÁî ÇÇÇÃ’Àº Ä¡·á°¡ ºÒ°¡´ÉÇÑ È¯ÀÚµéÀÇ Á¶·Â »ç¸ÁÀ» µ½´Â ÀÇ»ç¿Í À̸¦ ÃßÀûÇÏ´Â Çü»çÀÇ À̾߱⸦ ±×¸° ¼­½ºÆæ½º µå¶ó¸¶´Ù.   ±Ø Áß ÅÂÇ×È£´Â ±¤¼ö´ëÀå żº(±èÅÂ¿ì ºÐ)°ú ÇÔ²² »ç°ÇÀ» ÂÑ´Â ‘ºÎÇü»ç’·Î ºÐÇØ, Á¶·Â »ç¸Á »ç°ÇÀÇ ½Çü¿¡ ´Ù°¡¼­±â À§ÇØ ÇöÀåÀ» ´©ºñ°í ´Ü¼­¸¦ ...

KGM, Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø°ú ÀÚÀ²ÁÖÇà ±â¼úÇù·Â MOU

ÀÚÀ²ÁÖÇà °ü·Ã À¯·´ ¹ý±Ô ´ëÀÀÀº ¹°·Ð ¾ç»ê ±â¼ú È®º¸ ±â´ë
KG ¸ðºô¸®Æ¼(ÀÌÇÏ KGM)°¡ Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø (ÀÌÇÏ ÁøÈï¿ø)°ú ÀÚÀ²ÁÖÇà ±â¼ú °³¹ß MOU¸¦ ü°áÇÏ°í »óÈ£Çù·ÂÇϱâ·Î Çß´Ù. Áö³­ 28ÀÏ(¿ù) ÁøÈï¿ø º»»ç(´ë±¸½Ã ´Þ¼º±º ¼ÒÀç)¿¡¼­ ¿­¸° MOU ü°á½Ä¿¡´Â KGM ±Ç¿ëÀÏ ±â¼ú¿¬±¸¼Ò ¼ÒÀå°ú ÁøÈï¿ø ¼­ÀçÇü ¿øÀåÀ» ºñ·ÔÇÑ °ü°èÀÚµéÀÌ Âü¼®Çß´Ù. ÁøÈï¿øÀº ÀÚÀ²ÁÖÇàÂ÷ µî Â÷¼¼´ë ÀÚµ¿Â÷ ±â¼úÀ» °³¹ßÇÏ´Â °ü·Ã ¾÷ü¿Í ¿¬±¸±â°üÀ» Áö¿øÇϱâ À§ÇØ 2014³â ¼³¸³µÈ ½ÃÇè Àü¹® ±â°üÀ¸·Î, °í¼Ó ÁÖȸ·Î, ¹ü¿ë ½ÃÇè·Î µî ´Ù¾çÇÑ Á¶°Ç¿¡¼­ÀÇ ÀÚµ¿Â÷ ÁÖÇà ½ÃÇè ¹× Ãæ°Ý ³»±¸ ½ÃÇè Àåºñ µîÀÇ ½Ã¼³ ¹× ½ÃÇè Àη ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
±â¾Æ, Ú¸ ³»±¸Ç°ÁúÁ¶»ç ÀϹݺ귣µå 1À§ (2021-02-19)
akaBot and WEM APAC Join Hands, Showcasing No-code and Hyper... (2022-09-19)
1913³â ûÁÖ »ó½Åµ¿¿¡¼­ ¾´ ÇѱÛÁ¶¸®¼­ (2013-02-02)
´õÁ¸ºñÁî¿Â-ÇѸ²´ë, ¡®µðÁöÅÐ ÇコÄɾ Ȱ¼ºÈ­ (2021-12-16)
³ë½ºÆäÀ̽º, ģȯ°æ °Ü¿ï ÄÚµð Á¦¾È (2020-12-04)
MZ¼¼´ë 35.8%, µå¶ó¸¶ ¿©·¯ Æí ¸ô¾Æº»´Ù (2020-06-10)
³×ÆÄ, ¡®¸®Ä¿¹ö¸® ½æ¸Ó ½Ã¸®Á Ãâ½Ã (2021-06-22)
Ãë¾÷ ¸øÇߴµ¥ °±¾Æ¾ß ÇÒ ´ëÃâÀº ¡®583¸¸¿ø¡¯ (2021-09-30)
µÎ ¾ö¸¶¿Í ÇÔ²²ÇÑ º¸¸§ µ¿¾ÈÀÇ Çູ À̾߱â (2018-12-04)
À¯ºñ³Ê, ³ª¸¸ÀÇ °³ÀÎ ¼îÇθô ¡®¼¿¸¶ÄÏ¡¯ ¹«·á Á¦°ø (2020-03-25)
'±× ÇØ ¿ì¸®´Â' ³ëÁ¤ÀÇ, ¡®¾î¸¥ ¾ÆÀÌ¡¯ ¸Å·Â (2022-01-08)
¡®°í¾îÅØ½º ÀÎÇǴϾö¢â Á¦Ç° ºê·£µå¡¯ ½Å±Ô ·ÐĪ (2018-09-18)
ºÏ¶óÀÌÇÁ, ¡®¹«Á¶°Ç ÅëÇÏ´Â ¾ÐÃà ¿µ¾î¡¯ Ãâ°£ (2020-07-03)
'¾î°ÔÀÎ ¸¶ÀÌ ¶óÀÌÇÁ' ÀÌÁرâ, ¸¸´É Äɹ̷ (2022-04-18)
ÀåÇõ, ¡®¹«ºñ½ºÅ¸¼Ò¼ÈŬ·´¡¯ Ã⿬ (2014-03-24)
ƯÇ㡤Áö½ÄÀç»ê±ÇÀ¸·Î Æò»ý µ·¹ú±â (2022-07-27)
¾Ë¾ÆµÎ¸é ¾µ¸ðÀÖ´Â »çȸÀû°æÁ¦ °¡Ä¡¼Òºñ (2022-07-27)
°ø½Ä ä³Î ÆÄÆ®³Ê Á¦ÈÞ (2022-07-27)
HDÇѱ¹Á¶¼±Çؾç, À¯·´ ÇöÁö¿¡ R&D ÅõÀÚ È®´ë (2023-04-30)
±×·¡Á¦º»¼Ò ¡®Å𸶷ϡ¯ ¿¬Àç 30ÁÖ³â ÇÑÁ¤ÆÇ ¼¼Æ® (2023-04-30)
¸Þ°¡¸¶Æ®¸ô, ¿©¸§ ¹ÙIJ½º Àα⠻óǰ ÃÖ´ë 40% ÇÒÀÎ (2020-07-26)
MS, ¸»Ö¤ ù µ¥ÀÌÅͼ¾ÅÍ ¸®Àü ¼³¸³ (2021-04-29)
MZ¼¼´ë À§ÇÑ GS25 ¸ÆÁÖ ±¸µ¶ ¸â¹ö½Ê º¸Çè (2021-08-07)
º§·Î´ÙÀÎ ¶óÀÌ´õ, Áö¿À½½·¥°ú ´Ù³â°£ ÆÇ¸Å °è¾à (2020-05-10)
MultiBank Group Honored as Best Gold Broker of 2024 by FX Em... (2024-05-11)
       [ÀÌÀü][1]....[2350][2351][2352][2353][2354][2355][2356][2357][2358]...[3703][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..